Symposium on World Cancer Research on April 22-24, 2024 in Singapore, Singapore

WELCOME REMARK

The organizing committee sincerely welcome you to join in The 4th SYMPOSIUM ON WORLD CANCER RESEARCH (SWCR 2024), which will be held during Apr.22nd-24th, 2024 in Singapore.

SWCR 2024 includes plenary forum, 15 breakout streams, as well as poster exhibition in the three-day scientific program. The topics will focus on Cancer Genetics and Genomics, Cancer Screening and Early Detection, Cancer Therapy and Treatment, Cancer Metastasis, Tumor Microenvironment and different kinds of cancers/tumors, such as Lung Caner, Breast Cancer, etc.

SWCR 2024 is planned as a hybrid event. We are hopeful that many of you will be able to make the trip to the beautiful country to see old colleagues, and make new friends.

Website: https://swcr2024.lmsii.org/; https://swcr2024.vowcongress.cn/

Contact us: Ms. Lucy Hsieh Email: [email protected]

Topics:

Cancer Genetics and Genomics;

Cancer Biomarker and Diagnosis;

Immunology and Immunotherapy;

Prostate and Bladder Cancers;

New Therapeutics and Targets;

Tumor Microenvironment;

Breast Cancer;

Cancer Metastasis

Renowned Speakers of SWCR 2024

Prof. Iris Barshack, Sheba Medical Center, Israel;

Dr. Olivier Pardo, Imperial College London, UK;

Dr. Junichi Taguchi, Tokyo Midtown Clinic, Japan;

Prof. Angus G Dalgleish, St George’s University of London, UK;

Dr. Alessandra Longhi, Istituto Ortopedico Rizzoli Bologna, Italy;

Dr. Arul Earnest, Monash University, Australia

Organizing Committee

Hosting Organization

Life and Medical Sciences Innovation Institute(LMSII)

Operating Organization

Amazing Congress Co. LTD.

VOW Congress Inc.

Conference Coordinator

Ms. Lucy Hsieh

Scientific Committee Members

Dr. Mark Bradley, Professor, University of Edinburgh, UK

Dr. Ana I Faustino-Rocha, Researcher, Center for the Research and Technology of Agro-Environmental and Biological Sciences (CITAB), Portugal

Dr. Michael A Firer, Professor & Director, Ariel Center for Applied Cancer Research, Ariel University, Israel

Dr. Beibei Guo, Associate Professor, Louisiana State University, USA

Dr. Bee Luan Khoo, Assistant Professor, City University of Hong Kong, Hong Kong, China

Dr. Runhua Liu, Associate Professor, University of Alabama at Birmingham, USA

Dr. Khue Vu Nguyen, Visiting Professor, School of Medical Imaging, Jiangsu Vocational College of Medicine, China

Dr. Appu Rathinavelu, Executive Director, Rumbaugh Goodwin Institute for Cancer Research, Nova Southeastern University, USA

Dr. Alper Sevinc, Director of Medical Oncology, Medicalpoint Gaziantep Hospital, Turkey

Dr. Wenqing Yang, Co-founder & Chief Scientific Officer, Clinbridge Biotech Co. Ltd., China

 

Schedule of SWCR & CMB & PSCR 2024

Based upon GMT+8, Singapore Time

Apr. 22, 2024 (Monday)

8:30-12:00

CMB Hybrid Session: Genetics & Genomics

CMB Hybrid Session: Protein, Peptide and Proteomics

SWCR Hybrid Session: Case Studies/Clinical Experience

13:30-18:30

SWCR Hybrid Session: Cancer Biomarker and Diagnosis

SWCR Hybrid Session: Cancer Genetics and Genomics

CMB Hybrid Session: Breaking Research in Cell Biology

CMB Hybrid Session: Molecular Diagnostics & Biomarkers

20:30-22:00

SWCR Online Session: Plenary Forum of SWCR

Apr. 23, 2024 (Tuesday)

8:30-12:00

PSCR Hybrid Session: Cancers and Tumors

SWCR Hybrid Session: Cancer Cell and Molecular Biology

SWCR Hybrid Session: Tumor Microenvironment

CMB Hybrid Session: Signaling Pathways and Therapeutic Targets

13:30-18:30

PSCR Hybrid Session: Plenary Forum of PSCR

CMB Hybrid Session: Advances in DNA & RNA Research

SWCR Hybrid Session: New Therapeutics and Targets

SWCR Hybrid Session: Liver Cancer and Pancreatic Cancers

20:30-22:00

SWCR Online Session: Cancer Informatics and Precision Oncology

Apr. 24, 2024 (Wednesday)

8:30-12:00

SWCR Hybrid Session: Cancer Therapy and Treatment (Part 1)

PSCR Hybrid Session: Antibody and Vaccines

13:30-18:30

SWCR Hybrid Session: Lung Cancer

SWCR Hybrid Session: Immunology and Immunotherapy

CMB Hybrid Session: Biomaterials and Biological Engineering

PSCR Hybrid Session: Metabolic and Endocrine Disorders

20:30 -22:00

SWCR Online Session: Cancer Therapy and Treatment (Part 2)

Apr. 25, 2024 (Thursday)

8:30-12:00

PSCR Hybrid Session: Small Molecule Antagonists and Agonists

PSCR Hybrid Session: Infectious Diseases

PSCR Hybrid Session: Natural Products and Traditional Therapy

13:30-18:30

PSCR Hybrid Session: Inflammation and Immunology

PSCR Hybrid Session: Pharmacology and Pharmacogenomics

PSCR Hybrid Session: Pharmaceutics and Drug Delivery

PSCR Hybrid Session: Pharmaceutical Biology and Medical Chemistry